{"id":"NCT01764022","sponsor":"Biocad","briefTitle":"A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients","officialTitle":"Multicenter Randomized Double-blind Phase III Clinical Trial Comparing Safety and Efficacy of BCD-022 (CJSC BIOCAD, Russia) Used With Paclitaxel to Herceptin® Used With Paclitaxel in the First-line Treatment of HER2+ Metastatic Breast Cancer Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-10","primaryCompletion":"2015-03","completion":"2017-12","firstPosted":"2013-01-09","resultsPosted":"2016-10-24","lastUpdate":"2018-11-29"},"enrollment":225,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Human Epithelial Receptor (HER)-2 Positive Breast Cancer"],"interventions":[{"type":"DRUG","name":"Trastuzumab","otherNames":["BCD-022","Herceptin"]},{"type":"DRUG","name":"Paclitaxel","otherNames":["Taxacad"]}],"arms":[{"label":"BCD-022","type":"EXPERIMENTAL"},{"label":"Herceptin®","type":"ACTIVE_COMPARATOR"}],"summary":"BCD-022-02 is a double-blind randomized clinical trial comparing efficacy of BCD-022 (INN: trastuzumab) and paclitaxel to Herceptin and paclitaxel in HER2-positive metastatic breast cancer with pharmacokinetics substudy. The purpose of the study is to demonstrate the non-inferiority of efficacy and safety of BCD-022 compared to Herceptin. Also study includes pharmacokinetics assessment.","primaryOutcome":{"measure":"Overall Response Rate","timeFrame":"Day 127","effectByArm":[{"arm":"BCD-022 (CJSC BIOCAD)","deltaMin":56,"sd":null},{"arm":"Herceptin ® (F. Hoffmann-La Roche Ltd., Switzerland)","deltaMin":48,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":11,"exclusionCount":23},"locations":{"siteCount":36,"countries":["Belarus","India","Russia","Ukraine"]},"refs":{"pmids":["32819305"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":113},"commonTop":["Anemia","Neutropenia","Leucopenia","Lymphopenia","Hyperglycemia"]}}